Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reynolds

Showing results (61-70 of 433) with videos related to

Pageof 44
Sort By:
Journal of the National Cancer Institute|May 4, 2000
Eliminating publication bias: the effect of negative trial resultsT Reynolds
Journal of the National Cancer Institute|March 10, 2001
Preventive oncology recognizes 25 years of discoveriesT Reynolds
Annals of Internal Medicine|September 23, 2000
The ethics of placebo-controlled trialsT Reynolds
Journal of the National Cancer Institute|October 6, 2000
Model aims to reduce discrepancy between phase II, phase III trialsT Reynolds
Journal of the National Cancer Institute|October 6, 2000
How does a drug get to phase III trials?T Reynolds
Journal of the National Cancer Institute|August 16, 2001
BRCA1: lessons learned from the breast cancer geneT Reynolds
BMJ (Clinical Research Ed.)|September 22, 2000
Screening for Down's syndrome. A large independent trial would be usefulT Reynolds
Annals of Internal Medicine|February 22, 2001
Task force readying first wave of new prevention guidelinesT Reynolds
Journal of the National Cancer Institute|June 21, 2001
IARC shifts priorities as research needs changeT Reynolds
Journal of the National Cancer Institute|June 3, 1992
Cancer data bases expandingT Reynolds
Pageof 44

Showing results (61-70 of 433) with videos related to

Sort By:
Pageof 44
Journal of the National Cancer Institute|May 4, 2000
Eliminating publication bias: the effect of negative trial resultsT Reynolds
Journal of the National Cancer Institute|March 10, 2001
Preventive oncology recognizes 25 years of discoveriesT Reynolds
Annals of Internal Medicine|September 23, 2000
The ethics of placebo-controlled trialsT Reynolds
Journal of the National Cancer Institute|October 6, 2000
Model aims to reduce discrepancy between phase II, phase III trialsT Reynolds
Journal of the National Cancer Institute|October 6, 2000
How does a drug get to phase III trials?T Reynolds
Journal of the National Cancer Institute|August 16, 2001
BRCA1: lessons learned from the breast cancer geneT Reynolds
BMJ (Clinical Research Ed.)|September 22, 2000
Screening for Down's syndrome. A large independent trial would be usefulT Reynolds
Annals of Internal Medicine|February 22, 2001
Task force readying first wave of new prevention guidelinesT Reynolds
Journal of the National Cancer Institute|June 21, 2001
IARC shifts priorities as research needs changeT Reynolds
Journal of the National Cancer Institute|June 3, 1992
Cancer data bases expandingT Reynolds
Pageof 44